This statistic displays the global market shares of the top 10 medical technology companies for orthopedics in 2017 and 2024. In 2017, Zimmer Biomet accounted for 20.3 percent of the worldwide orthopedic medtech revenue market. Orthopedics is a branch of surgery that deals with musculoskeletal system conditions such as trauma, sport injuries, degenerative diseases, infections, and tumors.

Zimmer Biomet Holdings reported $22.73B in Market Capitalization this March of 2025, considering the latest stock price and the number of outstanding shares.Data for Zimmer Biomet Holdings | ZBH - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last March in 2025.

Zimmer Biomet Holdings stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

Download Free Sample
The regenerative medicine market research report identifies increasing prevalence of chronic diseases as one of the primary drivers propelling the growth of the market. This driver is expected to create several growth opportunities and entice market vendors to make significant investments.

The regenerative medicine market research report offers several other key information including:

CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will drive regenerative medicine market growth during the next five years
Precise estimation of the regenerative medicine market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the regenerative medicine market industry across North America, Europe, Asia, and ROW
A thorough analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of regenerative medicine market vendors

[Keywords] Market include Samay Surgical, Zimmer Biomet, DuPuy Synthes, WishBone Medical, Johnson & Johnson

[Keywords] Market include Stryker Corporation, Medtronic plc, Wright Medical Group Inc., DSM Biomedical, 3M Company

This statistic shows the leading companies for large joint reconstruction in the U.S. by market share as of 2017. According to the data, Zimmer Biomet held 34 percent of the large joint reconstruction market.

[Keywords] Market include PerkinElmer, Weatherford, InTech, Cuadrilla Resources, Zimmer Biomet Holdings Inc.

The global craniofacial implants market was valued at US$ 51.2 Million in 2022 and is expected to reach US$ 114.9 Million by 2033. The anatomical shaped implants segment with a market share of around 29.2% has topped the global market within the shape category and is expected to grow at a CAGR of 8.3% over the forecast period (2023 to 2033)

Data Points	Market Insights
Market Value 2022	US$ 51.2 Million
Market Value 2023	US$ 54.7 Million
Market Value 2033	US$ 114.9 Million
CAGR 2023 to 2033	7.7%
Market Share of Top 5 Countries	57.2%
Key Market Players	Implantech, Stryker, Matrix Surgical USA, Yuyao Jiusheng Medical Supplies Factory, Surgusil, L.L.P., GRAND AESPIO INC, Sebbin, Surgiform Innovative Surgical Products, Poriferous, Alpha Aesthetics (AART, Inc.), Henson Medical Inc., Guangzhou Wnhe Plastic Materials Co., Ltd, Calavera Surgical Design, Johnson & Johnson Medical GmbH (Depuy Synthes), Zimmer Biomet, KLS Martin Group, Silimed and Medartic AG.

Report Scope as Per Craniofacial Implants Industry Analysis

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2013 to 2022
Market Analysis	US$ Million for Value, Units for Volume
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, BENELUX, Russia, India, Thailand, China, Indonesia, Malaysia, Japan, South Korea, Australia, New Zealand, GCC countries, North Africa and South Africa.
Key Market Segments Covered	Procedure, Shape, End User, and Region
Key Companies Profiled	Implantech Stryker Matrix Surgical USA Yuyao Jiusheng Medical Supplies Factory Surgusil L.L.P. GRAND AESPIO INC Sebbin Surgiform Innovative Surgical Products Poriferous Alpha Aesthetics (AART, Inc.) Henson Medical Inc. Guangzhou Wanhe Plastic Materials Co., Ltd Calavera Surgical Design Johnson & Johnson Medical GmbH (Depuy Synthes) Zimmer Biomet KLS Martin Group Silimed Medartic AG.
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing	Available upon Request

[Keywords] Market include Orthofix International N.V., Stryker Corporation, Zimmer Biomet Holdings Inc., Ortho-SUV Ltd., Ortho SUV ltd.

The global polyethylene medical implant market is experiencing steady growth, projected to reach a value of $2.5 billion by 2025 and maintain a compound annual growth rate (CAGR) of 5% through 2033. This growth is driven by several factors, including the increasing prevalence of orthopedic surgeries, a rising geriatric population requiring joint replacements, and advancements in polyethylene formulation leading to improved implant durability and biocompatibility. The market is segmented by implant type (jaw, cheek, and other) and application (hospitals, orthopedic clinics, and other settings). Hospitals currently represent the largest application segment, driven by the complexity of procedures and the need for specialized equipment and expertise. However, the growth of orthopedic clinics and ambulatory surgical centers is anticipated to increase the market share of these segments in the coming years. Key players in the market, including Paragon Medical, Zimmer Biomet Holdings, and Stryker, are investing heavily in research and development to improve implant design, enhance biocompatibility, and expand their product portfolios. Competition is fierce, pushing innovation and driving down costs, thus making these implants more accessible to a wider patient population. The market’s geographic distribution shows a significant concentration in North America and Europe, driven by higher healthcare expenditure and advanced medical infrastructure. However, the Asia-Pacific region presents significant growth potential, fueled by rapid economic development, increasing healthcare awareness, and a burgeoning middle class. While the increasing cost of healthcare and stringent regulatory approvals pose challenges to market expansion, the overall outlook remains positive, driven by consistent demand for improved joint replacement and other medical implants made of polyethylene. The market is expected to witness further consolidation through mergers and acquisitions, as companies strive to gain a competitive edge and expand their geographic reach. Future growth will likely be influenced by technological advancements in materials science, the development of minimally invasive surgical techniques, and the ongoing demand for improved patient outcomes.

The Unicompartmental Knee Arthroplasty (UKA) system market is experiencing robust growth, driven by an aging global population, increasing prevalence of osteoarthritis, and advancements in minimally invasive surgical techniques. The market, estimated at $2.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% from 2025 to 2033, reaching approximately $4.2 billion by 2033. This growth is fueled by several factors. Firstly, the rising incidence of osteoarthritis, particularly in the knee, necessitates effective treatment options, with UKA offering a less invasive alternative to total knee replacement. Secondly, technological advancements, such as improved implant designs and navigation systems, enhance surgical precision and patient outcomes, further boosting market adoption. The segment of cemented fixation types currently holds a larger market share compared to uncemented types, but both segments are expected to experience significant growth driven by ongoing technological advancements and innovation within implant materials and design. Finally, the geographic distribution of the market shows a concentration in North America and Europe, with significant growth potential in emerging markets in Asia-Pacific and other regions as healthcare infrastructure improves and awareness of UKA procedures increases. This is further stimulated by growing demand in both adult and underage patient populations. The competitive landscape is characterized by a mix of established players and emerging companies. Key market players such as Zimmer Biomet, DePuy Synthes, and Stryker hold significant market shares due to their established brand reputation, extensive distribution networks, and continuous product innovation. However, the market also witnesses the emergence of several regional players and specialized companies that are developing innovative UKA systems and focusing on niche applications. These factors contribute to the market’s dynamic nature, characterized by both consolidation and fragmentation. The restraints to growth include high procedure costs and the suitability of UKA only for specific patient demographics and knee conditions. Nevertheless, continued improvements in implant technology and the growing patient pool are anticipated to drive market expansion throughout the forecast period, making UKA a significant segment within the broader orthopedics market.

The global knee reconstruction market is experiencing robust growth, driven by factors such as the rising prevalence of osteoarthritis, sports injuries, and accidents leading to knee damage. An aging global population, coupled with increased awareness of minimally invasive surgical techniques and improved implant technology, further fuels market expansion. The market is segmented by type (e.g., total knee replacement, partial knee replacement, revision surgery) and application (e.g., hospitals, ambulatory surgical centers). While the precise market size and CAGR are not provided, industry reports suggest a substantial market value, potentially in the billions, with a CAGR likely between 5% and 8% over the forecast period (2025-2033). This growth is underpinned by technological advancements offering improved implant durability, faster recovery times, and enhanced patient outcomes. However, high procedure costs, potential complications associated with surgery, and limited access to advanced healthcare in developing regions pose challenges to market growth. The competitive landscape is dominated by major players such as Arthrex Inc., Johnson & Johnson, and Zimmer Biomet, who are constantly innovating and expanding their product portfolios. Regional variations exist, with North America and Europe currently holding significant market shares due to higher healthcare expenditure and technological adoption rates, but developing economies in Asia-Pacific are witnessing a surge in demand, presenting lucrative growth opportunities. The forecast period (2025-2033) is expected to witness significant advancements in robotic-assisted surgery and personalized medicine for knee reconstruction. These innovations will likely drive market growth by improving surgical precision, reducing complications, and tailoring treatments to individual patient needs. Further market segmentation by surgical approach (e.g., anterior cruciate ligament (ACL) reconstruction, posterior cruciate ligament (PCL) reconstruction) will also be important for understanding the nuances of this dynamic market. Companies are investing heavily in research and development to create biocompatible and durable implants, alongside developing sophisticated data analytics tools for enhanced patient monitoring and post-operative care. The increasing focus on value-based healthcare will also influence the market, necessitating a demonstration of improved clinical and cost-effectiveness by manufacturers.

The global primary hip replacement system market is a substantial and rapidly growing sector within the orthopedic devices industry. Driven by an aging global population experiencing increased osteoarthritis prevalence and a rising demand for minimally invasive surgical procedures, the market is projected to experience significant expansion over the forecast period (2025-2033). Technological advancements, such as the development of improved implant materials (like ceramic-on-ceramic and metal-on-polyethylene) offering enhanced durability and reduced wear, are major drivers. Furthermore, the increasing adoption of robotic-assisted surgery and 3D-printed implants contributes to improved surgical outcomes and patient satisfaction, fueling market growth. While the market faces restraints like high procedure costs and potential complications associated with implant failure, the overall positive trajectory is sustained by a growing preference for joint replacement surgeries over conservative treatments among patients and a continuous improvement in implant technology and surgical techniques. The market is segmented by application (total hip arthroplasty and hip hemiarthroplasty) and by implant type (metal-on-polyethylene, metal-on-metal, ceramic-on-polyethylene, ceramic-on-ceramic, and ceramic-on-metal), with metal-on-polyethylene currently holding a dominant market share. Significant regional variations exist, with North America and Europe anticipated to maintain their leading positions due to higher healthcare expenditure and advanced medical infrastructure. However, the Asia-Pacific region is poised for substantial growth owing to increasing disposable incomes, improving healthcare access, and a burgeoning elderly population. Competition in the primary hip replacement system market is intense, with major players like Zimmer Biomet, Johnson & Johnson, Stryker, and Smith & Nephew dominating the landscape. These companies are investing heavily in research and development to enhance their product portfolios and expand their global presence. The competitive landscape is characterized by strategic partnerships, mergers and acquisitions, and the introduction of innovative products. Smaller companies are also contributing significantly, specializing in niche technologies or geographical markets. The market is expected to witness further consolidation in the coming years, with larger players seeking to acquire smaller companies to expand their product lines and enhance their market share. The increasing focus on value-based healthcare models and the need for cost-effective solutions will also shape the market dynamics in the coming years.

Get the sample copy of Trauma Fixation Devices Market Report 2025 (Global Edition) which includes data such as Market Size, Share, Growth, CAGR, Forecast, Revenue, list of Trauma Fixation Devices Companies (Stryker, Zimmer Biomet, Smith & Nephew, Auxein Medical), Market Segmented by Type (Internal Fixation Devices, External Fixation Devices), by Application (ASCs, Physicians Offices, Hospitals)

During the forecast period, the skin grafting systems market is expected to increase in size from US$ 884.83 Mn in 2022 to US$ 1,773.4 Mn by 2032. The demand for skin grafting systems is anticipated to grow at a CAGR of 7.2% during 2022-2032.

Attributes	Details
Skin Grafting System Market Value (2022)	US$ 884.83 Million
Market Forecast Value (2032)	US$ 1,773.4 Million
Market CAGR (2022 to 2032)	7.2%

Scope Of Report

Report Attributes	Details
Growth Rate	CAGR of 7.3% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion, Volume in Units and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product Type Wound Type End User Region
Region Covered	North America Latin America Europe East Asia South Asia Oceania Middle East & Africa
Key Countries Profiled	USA Canada Brazil Mexico Germany UK France Spain Italy China Japan South Korea Malaysia Singapore Australia New Zealand GCC South Africa Israel
Key Players	Zimmer Biomet B. Braun Medical Exsurco Medical, Inc. Aygun Surgical Instruments Co., Inc. De Soutter Medical Lutz GmbH & Co. KG Smith & Nephew Stryker Corp. Integra Lifesciences Holdings Corp. Humeca BV Surtex Instruments Limited

The global implantable medical devices market is projected to grow from USD 102.47 billion in 2024 to USD 238.09 billion by 2037, registering a CAGR of over 6.7% during the forecast period, from 2025 through 2037. Key industry players include Abbott, Boston Scientific Corporation, Zimmer Biomet Holdings, Stryker Corporation, among others.

The global small bone power tools market, valued at $215 million in 2025, is projected to experience steady growth, driven by several key factors. The increasing prevalence of orthopedic surgeries, minimally invasive procedures, and a rising geriatric population requiring joint replacements contribute significantly to market expansion. Technological advancements in power tool design, focusing on enhanced precision, ergonomics, and reduced invasiveness, further fuel demand. The market is segmented by application (hospitals, clinics, and other settings) and type (electric and pneumatic tools). Hospitals currently dominate the application segment, reflecting the high concentration of orthopedic procedures in these settings. Electric tools hold a larger market share than pneumatic tools due to their precision, versatility, and ease of use. However, pneumatic tools maintain a presence due to their robustness and cost-effectiveness in certain applications. Geographic growth varies, with North America and Europe currently leading, due to well-established healthcare infrastructure and high adoption rates of advanced surgical techniques. However, emerging markets in Asia-Pacific are poised for significant growth, driven by increasing healthcare spending and rising awareness of minimally invasive surgical procedures. Competitive dynamics are shaped by established players like ConMed, Stryker, and Johnson & Johnson, alongside several specialized manufacturers. These companies are focused on product innovation, strategic partnerships, and geographic expansion to secure their market position. While regulatory hurdles and high initial investment costs can pose challenges, the long-term growth prospects remain positive, driven by the continuously growing need for efficient and precise orthopedic surgical tools. The market's 3.5% CAGR indicates a consistent, albeit moderate, growth trajectory. This relatively modest growth rate may be influenced by factors such as the relatively mature nature of the market in developed regions and the cyclical nature of healthcare spending. However, continued innovation in areas such as robotic surgery integration and the development of smaller, more precise instruments will likely drive future growth, particularly in niche applications and emerging markets. The potential for consolidation among smaller players is also a notable factor to watch, with larger companies strategically acquiring smaller ones to expand their product portfolios and market reach. This consolidation is likely to further shape the competitive landscape in the coming years.

The Orthopedic Devices Market is valued at $50,000 Million and is experiencing robust growth with a CAGR of 5.5%. This expansion is fueled by several key factors. The aging global population is a significant driver, leading to an increased incidence of osteoarthritis, osteoporosis, and other orthopedic conditions requiring surgical intervention or device-based therapies. Technological advancements in materials science have resulted in the development of stronger, lighter, and more biocompatible implants, improving patient outcomes and extending the lifespan of devices. Furthermore, minimally invasive surgical techniques are gaining traction, reducing recovery times and hospital stays, thereby increasing the demand for smaller, more precise orthopedic devices. The rising prevalence of sports injuries, particularly among younger populations, also contributes to market growth, as does increased awareness and improved access to advanced orthopedic care in developing economies. Government initiatives promoting healthcare access and reimbursement policies supporting advanced orthopedic treatments further stimulate market expansion. Finally, the ongoing research and development efforts focused on creating innovative implant designs and materials ensures a continuous pipeline of new and improved orthopedic devices entering the market, ensuring sustained growth for the foreseeable future. Major players like DePuy Synthes, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet are at the forefront of this innovation, constantly striving to improve treatment options and expand their market share.

[Keywords] Market include Arthrex, Xtant Medical, Zimmer Biomet, DePuy, Wright Medical